WO2015103034A1 - Procédé en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche - Google Patents

Procédé en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche Download PDF

Info

Publication number
WO2015103034A1
WO2015103034A1 PCT/US2014/072109 US2014072109W WO2015103034A1 WO 2015103034 A1 WO2015103034 A1 WO 2015103034A1 US 2014072109 W US2014072109 W US 2014072109W WO 2015103034 A1 WO2015103034 A1 WO 2015103034A1
Authority
WO
WIPO (PCT)
Prior art keywords
film
mask
forming
aperture
substrate
Prior art date
Application number
PCT/US2014/072109
Other languages
English (en)
Inventor
Curt Binner
Kenneth A. Pelley
Original Assignee
Johnson & Johnson Consumer Companies, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Consumer Companies, Inc. filed Critical Johnson & Johnson Consumer Companies, Inc.
Priority to AU2014374017A priority Critical patent/AU2014374017B2/en
Priority to CN201480071872.5A priority patent/CN105873737A/zh
Priority to RU2016131259A priority patent/RU2676288C2/ru
Priority to ES14835741T priority patent/ES2703210T3/es
Priority to JP2016543679A priority patent/JP6517216B2/ja
Priority to CA2935219A priority patent/CA2935219C/fr
Priority to MX2016008679A priority patent/MX2016008679A/es
Priority to EP14835741.1A priority patent/EP3089854B1/fr
Priority to BR112016015347A priority patent/BR112016015347B8/pt
Priority to KR1020167020648A priority patent/KR102226596B1/ko
Publication of WO2015103034A1 publication Critical patent/WO2015103034A1/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/12—Making multilayered or multicoloured articles
    • B29C39/123—Making multilayered articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C41/00—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor
    • B29C41/02—Shaping by coating a mould, core or other substrate, i.e. by depositing material and stripping-off the shaped article; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C41/22—Making multilayered or multicoloured articles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C—APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C21/00—Accessories or implements for use in connection with applying liquids or other fluent materials to surfaces, not provided for in groups B05C1/00 - B05C19/00
    • B05C21/005—Masking devices
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C—APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05C9/00—Apparatus or plant for applying liquid or other fluent material to surfaces by means not covered by any preceding group, or in which the means of applying the liquid or other fluent material is not important
    • B05C9/06—Apparatus or plant for applying liquid or other fluent material to surfaces by means not covered by any preceding group, or in which the means of applying the liquid or other fluent material is not important for applying two different liquids or other fluent materials, or the same liquid or other fluent material twice, to the same side of the work
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/32—Processes for applying liquids or other fluent materials using means for protecting parts of a surface not to be coated, e.g. using stencils, resists
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/36—Successively applying liquids or other fluent materials, e.g. without intermediate treatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C39/00—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor
    • B29C39/02—Shaping by casting, i.e. introducing the moulding material into a mould or between confining surfaces without significant moulding pressure; Apparatus therefor for making articles of definite length, i.e. discrete articles
    • B29C39/12—Making multilayered or multicoloured articles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B12/00—Arrangements for controlling delivery; Arrangements for controlling the spray area
    • B05B12/16—Arrangements for controlling delivery; Arrangements for controlling the spray area for controlling the spray area
    • B05B12/20—Masking elements, i.e. elements defining uncoated areas on an object to be coated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31725—Of polyamide
    • Y10T428/31768—Natural source-type polyamide [e.g., casein, gelatin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31844—Of natural gum, rosin, natural oil or lac
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31855—Of addition polymer from unsaturated monomers
    • Y10T428/31935—Ester, halide or nitrile of addition polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31855—Of addition polymer from unsaturated monomers
    • Y10T428/31938—Polymer of monoethylenically unsaturated hydrocarbon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31971—Of carbohydrate

Definitions

  • Film products have a wide variety of uses. These include decorative window decals, plasters, adhesive bandages, and oral strips (both medicated and otherwise).
  • printing including stencil printing and screen printing
  • n processes tha t are capable of providing irregular shapes on substrates.
  • the printed materials remain on permanently joined to the substrates, such as printed text and graphics on paper, printed circuits in the electronics industry, and printed designs on clothing and signage.
  • integration of a carrying substrate i nto a printed element prevents the usage of the printed product separate from the substrate,
  • the process includes placing a mask over a substrate; delivering liquid film-forming compositions through the mask to the substrate; removing the mask to lea ve a multilayered raw shape on the substrate; and curing the multilayered raw shape to form the multilayered shaped film product disposed on the subst rate.
  • the mask has a delivery surface and an opposite subst rate-facing surface and at least one aperture having a design corresponding to the desired shaped film product.
  • the film- orming compositions are delivered through, delivery openings of a multistream nozzle.
  • the movement of the mask and the delivery of the first and second liquid film.- forming compositions to the mask aperture are controlled to provide a volu metric flow rate of the first and second liquid film- forming compositions to the mask aperture corresponding to the volume of a void defined by the mask aperture, aperture sidewalls and delivery openings of the nozzle immediately adjacent to the mask aperture.
  • the nozzle is in contact with the delivery surface of the mask.
  • Fig. 1 is a block diagram of a process according to one embodiment of the present invention.
  • Fig. 2 is a perspective view of a shaped multilayered film product according to an embodiment of the present in vention.
  • Fig. 3 is perspective view of a flatbed printing apparatus useful in one embodiment of the present invention.
  • Fig. 4 is cross section of the apparatus of Fig. 3.
  • Fig. 5A is a graph of the displacement of a piston in the bore of the positive displacement pump of Fig. 3.
  • Fig. 5B is a plan view of a mask correlated to the displacement of the piston in the bore of the positive displacement pump of Fig, 3.
  • Fig. 6 is a partial cross-section of a rotary printing system useful in an alternate embodiment of the present invention.
  • Fig. 6A is a detail of the nozzle and stencil of Fig. 6.
  • Fig. 7 is a perspective view of a shaped multilayered film product according to an alternative embodiment of the present invention having a split second layer.
  • Fig, 8 is a perspective view of a multistream nozzle showing the nozzle openings for delivery of film- forming composition(s) to a mask according to an alternative embodiment of the present invent ion.
  • Fig, 9 is a perspective view of a shaped multilayered film product according to an alternative embodiment of the present invention having three zones across each layer thereof.
  • Fig, 10 is a perspective view of a shaped multilayered film product accordin; to an alternative embodiment of the present invention having an island formed of a different composition on the upper layer thereof,
  • the present invention relates to a process and apparatus for forming multilayered shaped film products.
  • the following description is presented to enabli one of ordinary skill in the art to make and use the invention.
  • Multilayered shaped film products may have a w ide variety of uses, ' These include household and recreational uses, such as decorative decals for windows and wails, temporary tattoos (such as body decals), healthcare dev ices such as medicated and/or absorbent plasters, adhesive bandages and other wound coverings oral strips also known as a "consumable film” (medicated, therapeutic, and cosmetic), other body strips, such as moisturizing, acne treatment, lightening of dark circles, melisma, cellulite, delivery of vitamins, treatment of eczema, psoriasis, and the like.
  • household and recreational uses such as decorative decals for windows and wails, temporary tattoos (such as body decals), healthcare dev ices such as medicated and/or absorbent plasters, adhesive bandages and other wound coverings oral strips also known as a "consumable film” (medicated, therapeutic, and cosmetic), other body strips, such as moisturizing, acne treatment, lightening of dark circles, melisma,
  • the term '"integral film product” variants thereof relate to a fil m product that is sufficiently robust to permit handling for a desired purpose separate from any supporting substrate. The product is removable from a substrate for use independent of the substrate.
  • film-forming composition varia nts thereof relate to a composition that is capable of forming, by itself or i n the presence of an additional agent, a continuous film on a substrate.
  • raw shape variants thereof relate to the shaped volume of film-formi ng composition disposed on a substrate through an apertured mask.
  • the raw shape generally requires further processi ng, such as integration, to transform it into an integral film product.
  • multilayered shaped film product and ariants thereof relate to thin products with two or more distinct l ayers (not mixed or homogeneous. Prod ucts with layers contai n ing different characteristics such as: adhesion, flavor, color, texture, etc. Layers may be continuous, intermittent, or adjacent.
  • the term "tessellated" and variants thereof relate to a planar surface having a pattern of flat shapes havi ng no overlaps or gaps. Thus, there is no "'ladder waste between the shapes.
  • FIG. 1 is a high level flo chart of a process for forming multilayered shaped film products.
  • a first Step 10 includes forming a mask having an aperture.
  • a second Step 20 includes placing the mask over a substrate.
  • a third St ep 30 includes delivering a pluralit y of film-forming compositions th rough the mask to the substrate to form a multilayered raw shape.
  • a fourth Step 40 includes removing the mask.
  • a fifth Step 50 i cludes solidifying the multilayered raw shape to form the shaped film product.
  • a shaped film product 100 according to one embodiment of the invention is shown in Fig, 2.
  • the multilayered shaped film prod uct 100 has a variable width measured perpendicular to a longitudi nal axis x-x, and the product is narrow at a first end 102, increases to a maximum width , and terminates w ith a rounded second end 104, opposite the first end 102.
  • the film product includes at least a first layer 106 and a second layer 108.
  • the innovations of the present invention allow the shape to be as simple or complex as desired.
  • the shape can be relatively complex—the kind of shape that would produce excessive ladder waste in a die-cutting operation.
  • the minimum ladder waste produced during the printing of a pattern of nested circles is about 20% (based on circles arranged in straight columns and rows touching at the quadrants).
  • Step 10 involves forming a mask having at least one aperture corresponding to a ra shape.
  • Print masks are known in the art. They can include without limitation stencils, tapes, and the like. While the exact fabrica tion of the print: masks is not critical to the present invention, our invention makes is possible to form relatively thick integral film prod ucts and therefore, use relatively thick masks.
  • the mask has a thickness of at least about 0.05 millimeters ("mm").
  • mm millimeters
  • the mask has a thickness of between about 0.05 mm and about 0.3 mm, more preferably, between about 0.1 and about 0.2 mm.
  • thick integral film products can be made using a mask having a thickness of greater than about 0,2 mm, preferably between about 0.2 and about 2 mm, preferably between about 0.4 mm and about 1 mm.
  • the thickness of the mask is not critical, while in other embodiments, the present invention makes possible the formation of integral film products with previously unknown thicknesses.
  • the thickness of the mask generally determines the maximum thickness of the integral film product. The relationship is determined by the nature of the film- forming composition and the mechanism by which the composition solidifies. For example, hot melt and hydrocolloid film-forming compositions generally produce a product thickness that is essentially equivalent to the mask thickness. Foaming film-forming compositions can also be used and may provide solidified films having a thickness substantially equivalent to the thickness of the mask, or possibly even thicker. Sol vent or other carrier-based compositions will lose thickness as the product solidifies. The reduction in thickness is generally related to the solids content of the composition. We have found that a solids content of 30-40% delivers an integral film product having a thickness of about 50% of the mask thickness.
  • masks ca n be made of structural materials, including without limitation: metals, such as aluminum alloy, stainless steel, J i alloy, Cr alloy or the like: resins, such mask as poiyimide, polyester, epoxy, polycarbonate, polyethyl ne, polyethylene terephthalate (PET), polypropylene or the like; glass; paper; wood; or cardboard, as well as combination thereof.
  • metals such as aluminum alloy, stainless steel, J i alloy, Cr alloy or the like
  • resins such mask as poiyimide, polyester, epoxy, polycarbonate, polyethyl ne, polyethylene terephthalate (PET), polypropylene or the like
  • glass paper; wood; or cardboard, as well as combination thereof.
  • the mask body may be made of a composite material, such as glass fiber filled polyimides, polyesters, or epoxies.
  • the mask body is formed in a sheet from these materials.
  • the thickness of the sheet may be from 20 to 2000 microtis ( ⁇ ), although for ease in handling and other considerations, the thickness is preferably from 20 to 80 ⁇ .
  • the mask has a uniform thickness.
  • the mask may have a thickened central portion along the machine direction and tapered ends.
  • An example of a mask according to one embodiment of the present invention, useful in the formation of the shaped film product 100 of Fig. 2 is a mask 200 that may be used in the flatbed printing apparatus shown in Fig. 3.
  • the mask 200 includes an impermeable mask portion 202 which defines at least one aperture 204.
  • the mask 200 is placed over a substrate 206 in Step 20.
  • This substrate 206 may be an endless belt (a continuous flexible web, linked platens, and the like), or it may be a web that carries the resulting shaped product.
  • the shaped product may be permanently attached to the web, or it may be releasably attached to a web, such as a release liner.
  • Typical release surfaces may include silicone, polytetrafluoroethyiene (PTFE), waxes, polymers, polished metals, or combinations thereof.
  • the process may employ flatbed appara tus or rotary apparatus.
  • the printing apparatus will have a support 208 for the substrate 206 a nd system for delivering a film-forming composition through the mask aperture 204 (Step 30).
  • the system includes a plurality of film -forming composition reservoirs (not shown), a multistream nozzle 210, a multichambered pump 212 (or multiple pumps), and a pump con roller (such as a cam 214).
  • the system for delivering the film-forming composition interacts with the mask 200 to provide appropriate volume of film-forming composition to the mask to accurately fill the void volume in the mask aperture 204 ' below the nozzle 210 during relative motion between the mask and nozzle.
  • This relative motion (shown in Fig. 4 as arrow 216) defines a machine direction.
  • the system includes a multistream nozzle 210 arranged and configured to bear against an upper surface 218 of the mask 200.
  • the lower surface 220 of the mask 200 is in contact with the substrate 206. if the nozzle applies sufficient force against the substrate and mask, it will form a seal with the upper surface of the mask and between the lower surface and the substrate effective to minimize leakage of the film-forming compositions 222, 223.
  • the nozzle 210 has a plurality of delivery openings 224 defining a machine direction dimension and a cross-direction dimension.
  • the cross-direction dimension is greater than the maximum cross-direction dimension of the a t least one aperture 204 formed in the mask 200.
  • the substrate 206, mask sidewalls 226 and the projection of the delivery openings 224 of the multistream nozzle 210 define a void volume 228 when the nozzle is disposed over at least a portion of the mask ape:rture204, and the pump is controlled to output a volume of the fil -forming compositions 222, 223 to the delivery openings 224 corresponding to that void volume.
  • This void volume can change during the relative motion between the nozzle 210 and mask 200, so the volu me of the fil -forming composition outpu t to the delivery openings 224 will change with the ch anging void volume.
  • the output of the pump 212 can be controlled through control means known to those of ordinary skill in the art.
  • the mask 200 can be placed in proximity to a cam 214 that is coupled to a piston pump form of a multichambered positive displacement pump 212,
  • the nozzle 210 is movable across the upper surface 218 of the mask 200 defining the mask aperture 204.
  • the multistream nozzle 210 is connected to a multichambered positive displacement pump 212 having a plurality of cavities or bores containing the film-forming compositions 222, 223.
  • a cam follower 230 engages the earn 214.
  • the earn profile correlates to the void volume defined by the substrate 206, mask sidewalk 226 and nozzle 210, as described above.
  • the cam 2.14 urges the cam follower 230 to move a piston in the bore of the pump to output, a volume oi film-forming compositions 222, 223 corresponding to the void volume adjacent the delivery opening 224 of the nozzle 210.
  • These compositions 220, 221 form first film layer 106 and second film layer 108 of Fig. 2, respectively.
  • the output volumetric flow of the positive displacement pump 2.12 corresponds to the changing void volume as the nozzle 210 moves along the mask 200, there is minimal disturbance to fl uid flow.
  • the flow is substantially laminar from the delivery openings to the substrate. This minimizes or even eliminates significant mixing of the two film-forming compositions at their interface.
  • composition delivery between the various delivery openings 224 can vary from 0 to 100% of the mask aperture volume adjacent the combined delivery openings.
  • a resulting multilayered shaped film product may have a single layer at one end formed by a first film-forming composition from a first delivery opening 224, a second la yer may start at some point along the length of the product by replacing some flow from the first delivery opening with flow from an adjacent second delivery opening of a second film -forming composition.
  • the proportion of first and second film-forming compositions may vary along the delivery path. Indeed, the delivery of the first film-forming composition, may terminate, and the second end of the resulting multilayered shaped film product may have only one layer formed of the second film -forming composition.
  • the formulation viscosity and rheology can affect the amounts of film -forming composition and the nature of the transition between film-forming composition deliveries. For example thick 'pasty' materials will require an abrupt on / off transition. Thin 'runny' materials will permit gradual variation of layer thickness.
  • the delivery openings 224 may have any shape appropriate for delivering the film-forming composition.
  • a particularly preferred delivery opening is a rectangular slot having a cross-direction dimension that is substantially greater than the machine direction dimension.
  • Figs. 5A and SB The rel tionship between the film-forming composition delivery and the motion along the mask aperture is shown in Figs. 5A and SB, t g. 5A shows a graph of the displacement of the cam follower 280 that is coupled to a
  • Fig. 5B is a plan view of a mask 200 correlated to the displacement of the cam follower 230 caused by movement along the cam 214 in the direction shown in Fig. 4.
  • a comparison of Figs. 5A and 5B shows tha t no film-forming composition is provided to the mask aper ture until the nozzle reaches the left edge of the mask aperture. This is shown as a slope of zero for displacement line 232 of Fig. 5 A.
  • the volumetric flow ra te increases as the aperture width increases (shown by the grea ter slope of displacement line 232 of Fig. 5A). Once the maximum width of the mask aperture is reached, the volume t ric flow rate decreases to zero at the right edge of the mask aperture.
  • volumetric pumps and volumetric flow controllers may be used and correlated to the relative mo tion of the nozzle and mask aperture.
  • computer co t rolled volumetric pumps can ary the fluid dispense rate to portions of the mask aperture to provide the volume of film-forming co mposition correspondi ng to the void volume. Additional, non-limiting representative examples of such pumps and controls include additional examples and the like.
  • step 40 the first mask 200 is removed leaving a first raw shape 234 deposited on the substra te 206.
  • a rotary stencil generally delivers a superior quality shaped film product.
  • the raw shape 234 is solidified into the shaped film product 100.
  • the shaped film product 100 may be permanently attached to the substrate 206, or the substrate 206 may be a release liner to permit the product to be removed therefrom for use independent of the substrate.
  • the exact nature of the solidifying station is not critical to the present invention.
  • the raw shape may be heated to drive off volatile carriers, such as such as water and organic solvents.
  • the solidifying can be through providing energy, such as U V light to cross-link or otherwise "'cu re" one or more polymeric film-forming components. If one or more film-forming components is a hotmelt composition, the solidifying can be as simple as allowing the raw shape to cool below a melt or glass transition temperature.
  • additional layers may be added by incorporating additional fluid delivery components to the film-forming composition delivery system to provide more than two layers in the raw shape.
  • the present inven tion is particularly suited to apply ra w shapes in layers as there is minimal disturbance to fluid flow- with the correlated volumetric output of the pump, as described above.
  • the shaped film product may be permanently attached to the web, or it may be releasably attached to a web, such as a release liner.
  • a release lined web as the substrate
  • the release lined web may be used as a carrier and packaged with the shaped film product in appropriate sized primary packaging until delivered to a consumer. The consumer may then remove the shaped film product from the substrate and use it as desired.
  • the process according to the present invention employs an endless belt having a releasabie surface or other substrate integrated into the manufacturing equipment, the shaped film product is removed from the releasabie surface of the substrate and packaged for delivery to a consumer.
  • the shaped film product may have an adhesive su rface, such as in a medicated piaster, or it may have non-tacky surfaces, such as in an oral strip.
  • a rotary printing system 300 shown in Fig. 6 a nd 6A may be used.
  • the film-forming composition is applied with a multistream nozzle 302.
  • a printing drum 304 includes at least one mask aperture 306. The rotation of the drum 304 indexes a mask aperture 306 to the multistream nozzle 302.
  • a controller such one or more elements to identify and read mask aperture position, correlates the controlled volumetric delivery of film- forming composition to the delivery opening of the nozzle (as described above).
  • the film -forming composition is delivered to the interior of the drum 306 via a conduit from a reservoir (not shown) void volume defined by the nozzle 302, mask sidewalk 308 and substrate 310, again, as described above.
  • the multilayered raw shape 312 then moves in the direction of arro 314 for further processing.
  • the above processes have described substantially uniform layers of the film-forming composition in the cross-direction o the process, it will be recognized that one or more layers may be formed of adjacent strea ms of film-forming composition.
  • the nozzle and delivery opening providing the second film- forming composition 223 in Fig. 4 (a nd thus second layer 108) could be divided at the machine axis to provide two adjacent streams of dissimilar film-forming compositions to provide the product of Fig. 7 having two second layers 108a a nd 108b— one on either side of a center line of the product.
  • a multistream nozzle 800 as shown in Fig. 8 having an array of nine zones 802-810 can be used to deliver up to nine different film- forming compositions in three layers.
  • the leading row of zones 802-804 can lay down a first layer on a substrate
  • the second ro of zones 805-807 can lay dow n a second lay r er on the first layer
  • a d the third row of zones 808-810 can lay down a third layer on the second layer.
  • a striped shaped multilayered fil m product may be formed.
  • a particular zone, such as zone 802 may deliver sufficient flow of film-forming composition therethrough to completely fill the void in the mask to provide a single, uniform layer along the length of the resulting product.
  • a result o the use of the multistream nozzle 800 can be tri -layered shaped multilayered film product 900 of Fig. 9. '
  • the first layer 902 (formed by zones 802- 804) may form the base layer
  • the second layer 904 (formed by zones 805-807) may form the intermediate layer
  • the third layer 906 (formed by zones 808-81.0) ma form the top layer.
  • each of the nine zones of the multistream nozzle 800 of Fig. 8 can deliver a different composition to form three stripes of differing compositions along the product, e.g. a first strip 908 formed by zone 810, a second stripe 910 formed by zone 809, and a third strip 912 formed by zone 808.
  • a wide v ariet y of product forms may be produced.
  • a shaped multilayered film product 1000 having an island 1002 in an outer layer is shown. This product can he formed by beginning to deliver a first film-forming composition to a first end 1 04 (e.g., through each of zones 802-804 with sufficient flow rate to fill the void in the mask), creating one thick layer across the width of the product at first end 1004.
  • the multistream nozzle 800 arrives at a point of the mask corresponding to point "x" in Fig.
  • the central nozzle 803 reduces its flow rate by 50%, and the central nozzle 806 of the second row provides a second film-forming composition to compensate for this reduced flo w rate of nozzle 803.
  • the central nozzle 806 of the second row is shut off, and either central nozzle 803 resumes delivery of the first film-forming composition at a full (low rate, or alternately, central nozzle 809 of the third row delivers the first film-forming composition to compensate for shut off of nozzle 806 as the multistream nozzle 800 continu es to the second end 1006 of the shaped multilayered film product 1000.
  • the slot nozzle opening (width) generally equals the maximum pattern width. Pressing the nozzle against the stencil surface creates a dynamic seal. Hence, the effective nozzle width naturally changes as the stencil opening passes across the nozzle.
  • Capillary action can draw the liquid film-forming composition into narrow gaps. Stenciling in a flat plane works best with the quick removal of the stencil from the substrate to avoid liquid wicking between. Capillary action can create defects such as feathered and rough edges.
  • Rotary stenciling (stencil in a cylinder form) minimizes the effects of capillary action, because stencil contact, with the substrate is along a line tangent to the cylindrical. Increasing web (substrate) speed can itrtprove this further.
  • Print thickness is controlled by stencil thickness (and the corresponding liquid flow ).
  • the minimum stencil thickness is a material strength issue.
  • Stainless steel 0.006 inch th ick may be a practical lower limit with current technology.
  • 0.006 thick stencil yields dry film thicknesses in the range of 0.002— 0.003 inch depending upon liquid solids content.
  • Multistream printing of an island according to the present invention takes advantage of the laminar flow of the film-forming composition during printing. This also avoids mixing between layers.
  • the film-forming compositions employed in the present invention may be in the form of a hotmelt composition, a solid material that can be melted to form a flowable liquid and deposited to form a raw shape which can then cool to form the integral film product.
  • the film-forming composition may include at least a film forming component and a carrier. Additional components may include, without limitation, emulsifiers, surfactants, plasticizers, active ingredients, fragrances, coloring agents, flavorings, and other components known to those of ordinary skill in the art.
  • the carrier is preferably a liquid and may be a solvent or diluent. Preferred carriers include water and alcohols.
  • the w a ter soluble polymers of the present inven tion possess film forming properties useful producing the films of the present invention.
  • Many water soluble polymers may be used in the films of the present inven tion.
  • a representative, non- limiting list includes pullulan, cellulose ethers (such as hydroxypropy methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose), polyvinyl pyrrolidone, c arboxy methyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylie acid.
  • methylmethacrylate copolymers carboxyvinyl polymers, amylose, starches (such as high amylose starch and hydroxypropylated high amylose starch ⁇ , dextrin, pectin, ehitin, chitosan, levari, elsinan, collagen, gelatin, zein, gl uten, soy protein isolate, whey protein isolate, casein and/or mixtures thereof.
  • the carrier is water. In alternate embodiment,
  • organic solvents which have been conventionally used can be employed as the solvent, A. representative, non-!irnlt ng list, of useful solvents includes monovalent alcohols such as methanol, ethanol, propanol, butanol, 3- methoxy-3-niethyi-l.-biitanoI, and 3-niethoxy-l-butanol; alkylcarboxylic acid esters such as methyl-3- inethoxypropionate, and e t hyl- 3 -ethoxypro i on ate; polyhydric alcohols such as ethylene glycol, diethylene glycol, and propylene glycol; polyhydric alcohol deriv atives such as ethylene glycol mono me thy!
  • ether ethylene glycol monoethyl ether, ethylene glycol monopropyi ether, ethylene glycol monobutyl ether, propylene gly col monomethy! ether, propylene glycol monoethyl ether, propylene glycol monopropyi ether, propylene glycol monobutyl ether, ethylene gly col monomethy! ether acetate, ethylene gly col monoethyl ether acetate, and propylene glycol mono methyl ether acetate: fatty acids such as acetic acid, and propionic acid; ketone such as acetone, methyl ethyl ketone, and 2-heptanone. These organic solvents may be used alone, or in combination.
  • the film product may also contain at least one surfactant, including anionic, amphoteric, non-ionic, a nd ca iionic surfactants or mixtures thereof,
  • anionic surfactants includes, alone or mixed, salts (for example salts of alkali metals, such as of sodium, ammonium salts, salts of amines, salts of amino - alcohols or magnesium salts) of the following compounds: aikyl sulphates, aikylether sulphates, aikylamidoether-su!phates, alkylarylpolyether-sulphates, monoglyceride sulphates, alky!
  • salts for example salts of alkali metals, such as of sodium, ammonium salts, salts of amines, salts of amino - alcohols or magnesium salts
  • suiphonates aikyl phosphates, alkylamide suiphonates, alkaryl suiphonates, alpha-olefm sulphonat.es, paraffin suiphonates; aikyl sulphosuccsnates, aikylether sulphosuccinates, alkylamide-sulphosuccinates, alky! sulphosuccinamates, aikyl sulphoacetates, aikylether phosphates, acyl sarcosinates, acyl isethionates and IN -acyl taurates, the alky!
  • the salts include those of fatty acids, such as the salts of oleic, ricinoleic, palmitic, stearic acids, acids of copra oil or of hydrogenated copra oil, acyl lactylates whose aeyl radical has 8 to 20 carbon atoms, alkyl D-galactoside uronic acids and their salts as well as the polyoxyalkylenated alkyl(C6-C24)ether ca rboxylic acids, the poly oxyalkyl enated alkyi(C6-C24)aryl ether carboxylic acids, the polyoxyalkylenated alkyl(C6-C24)amido-ether carboxylic acids and their salts, for example those having from 2 to 50 ethylene oxide groups, and mixtures thereof.
  • a representative, non-li miting list of amphoteric surfactants includes, alone or mixed, the derivati ves of secondary or tertia ry aliphatic amines w herein the aliphatic radical is a linear and branched chain with 8 to 22 carbon atoms and comprises at least o e hydrosolubilizing anionic group (for example carboxylate, suiphonate, sulphate, phosphate or phosphonate); the alkyl (C8-C20) betaines, the sulphobetaines, the alkyl (C8-C20) amidoalkyl (C1-C6) betaines such as
  • cocoamidopropyl betaine or the alkyl (C8-C20) amidoalkyl (C1-C6) sulphobetaines are examples of cocoamidopropyl betaine or the alkyl (C8-C20) amidoalkyl (C1-C6) sulphobetaines.
  • a representative, non -limiting list of non-ionic surfactants includes, alone or mixed, alcohols, a pha-diols, alkyl phenols or polyethoxylated, polypropoxylated or polyglycerolated fatty acids, having an aliphatic chain with for example 8 to 18 carbon atoms, where the number of ethylene ox ide or propylene oxide groups ca optionally be in the range from 2 to 50 and the number of glycerol groups can optionally be in the ra nge from 2 to 30.
  • plasticizer known in the pharmaceutical art is suitable for use in the film product.
  • plasticizer include, but a re not limited to, polyethylene glycol; glycerin; sorbitol; triethyl citrate; tribuyl citrate; dibutyl sebecate; vegetable oils such as castor oil; surfactan ts such as polysorbates, sodium lauryl sulfates, and dioctyl- sodium sulf ⁇ succinates; propylene glycol; mono acetate of glycerol; diacetate of glycerol; triacetate of glycerol; natural gums and mixtures thereof.
  • the film product of the present invention may also contain at least o ne colorant, such as a pigment or dyestuff.
  • a pigment or dyestuff examples include, but are not limited to, inorganic pigmen ts, organic pigments, lakes, pearlescertt pigments, irridescent or optically variable pigments, and mixtures thereof.
  • a pigment should be understood to mean inorganic or organic, white or colored particles.
  • Said pigments may optionally be surface-treated within the scope of the present invention but are not limited to treatments such as silicones, perfluorinated compounds, lecithin, and amino acids.
  • inorganic pigments useful in the present in vention include those selected from the group consisting of rutile or anatase titanium dioxide, coded in the Color Index under the reference CI 77,891; black, yellow, red a d brown iron oxides, coded under references CI 77,499, 77,492 and, 77,491; manganese violet (CI 77,742); ultramarine blue (CI 77,007); chromium oxide (CI 77,288); chromium hydrate (CI 77,289); and ferric bine (CI 77,510) and mixtures thereof.
  • organic pigments and lakes useful in the present in vention include, but are not limited to, D&C Red No. .19 (CI 45,170), D&C Red No. 9 ⁇ CI 15,585), D&C Red No. 21 ⁇ CI 45,380), D&C Orange No. 4 (CI 15,510), D&C Orange No. 5 (CI 45,370), D&C Red No. 27 (CI 45,410), D&C Red No. 13 (CI 15,630), D&C Red No. 7 (CI .15,850), D&C Red No. 6 (CI 15,850), D&C Yellow No. 5 (CI 19,140), D&C Red No. 36 (CI 12,085), D&C Orange No. 10 (CI 45,425), D&C Yellow No. 6 (CI 15,985), D&C Red No. 30 (CI 73,360), D&C Red No.3 (CI 45,430) and the dye or lakes based on cochineal carmine (CI 75,570) and mixtures thereof.
  • pearlescent pigments useful in the present invention include those selected from the group consisting of the white pearlescent pigments such as mica coated with titanium oxide, mica coated with titanium dioxide, bismuth oxychloride, titanium ox chloride, colored pearlescent pigments such as titanium mica with iron oxides, titanium mica with ferric blue, chromium oxide and the like, titanium mica with an organic pigment of the above-mentioned type as well as those based on bismuth oxychloride and mixtures thereof.
  • white pearlescent pigments such as mica coated with titanium oxide, mica coated with titanium dioxide, bismuth oxychloride, titanium ox chloride
  • colored pearlescent pigments such as titanium mica with iron oxides, titanium mica with ferric blue, chromium oxide and the like
  • titanium mica with an organic pigment of the above-mentioned type as well as those based on bismuth oxychloride and mixtures thereof.
  • Any thickener known in the art may optionally be added to the dim.
  • Suitable thickeners include, but are not limited to, cyclodextrin, crystallizable carbohydrates, and the like, and derivatives and combinations thereof.
  • Suitable crystallizable carbohydrates include the monosaccharides and the oligosaccharides.
  • the aldohexoses e.g., the D and L isomers of ailose, altrose, glucose, reiannose, gulose, idose, galactose, talose
  • the ketohexoses e.g., the 1) and L isomers of fructose and sorbose along with their hydrogenated analogs: e.g., glucitoi (sorbitol), and mannitol are preferred.
  • the 1,2- disaccharides sucrose and trehalose the 1,4-disaccharides maltose, lactose, and ceilobiose, and the 1,6-disaccharides gentiobiose and melibiose, as well as the trisaccharide raffinose are preferred along with the isomerized form of sucrose known as isomaltulose and its hydrogenated analog isomalt.
  • Other hydrogenated forms of reducing disaccharides such as maltose a nd lactose
  • maltitoi and lactitol are also preferred.
  • the hydrogenated forms of the a!dopentoses e.g., 1
  • the hydrogenated forms of the aidotetroses e.g., D and L erythrose and threose are suitable and are exemplified by xylitol and erythritol, respectively.
  • Preservatives known in the art may optionally be added to the film. Suitable Preservatives include, but are not limited to Benzalkonium Chloride, Benzyl Alcohol, 2-Bromo-2-Nitropropane, Butylparaben, Chlorhexidine Digluconate, Chlorphenism, Dehydroacetic Acid, Citric Acid, Diazolidinyi Urea, DMDM
  • Hydantoin Ethylparaben, F ormaldahyde, imidazolidinyl Urea, Isobutylparaben, Methylisothiazolinone, Methylparaben, Phenoxyethanol, Polyaminopropyi biguanide, Potassium Sorbate, Propylparaben, Quaternium— 15, Salicylic Acid, Sodium benzoate. Sodium Dehydroacetate, Sodium Metabisulfite, Sodium
  • Salicylate Sodium Sulfite, Sorbic Acid, Stearalkonium Chloride, Tr closan, and Zinc Pyrithione.
  • microbeads or other particulate materials may be incorporated and used as "scrubbing particles” or “exfoliates” in film products used in personal care products such as facial scrubs and body washes.
  • the microbeads are small particles, generall having a particle size of less tha n about 1,000 ⁇ , oft en less than about 750 ⁇ .
  • topical compositions and/or skin cleansing compositions incorporate microbeads or particulates havi ng a size of less than about 300 ⁇ , and preferably, less than about 100 ⁇ .
  • Particulates such as pumice can range from 35-1400 urn; topical compositions generally employ pumice having a particle size of about 100 ⁇ , The particle size should be taken into consideration when employing a screen mask, as the particle size is generally less than about 1/3 of the opening in the screen. For larger particles it is more advantages to use stencil because there are screen limitations to consider.
  • the microbeads can be a generally homogeneous material and can comprise pumice, polyethylene, glass, aluminum oxide, titanium dioxide, celluloses, such as Hydroxypropyl Methyicellulose
  • the microbeads can be in the form of microencapsulated particles in which desirable material is encapsulated in a covering material to delay the release of the material to the environment.
  • the microencapsulated particle may include adhesives and/or one or more benefit agents described in more detail below.
  • the film-forming composition for example as shown in Figs. 2 and 3, includes a benefit agent.
  • the resulting multilayered film product 100 has a first surface 110 formed on a releasable surface of the substrate, and a second surface 112 opposite thereof.
  • the first surface 110 is arranged and configured to deli er the benefit agent therethrough.
  • the first surface 110 may be protected by a release finer on a flexible substrate during manufacture and storage prior to use by a consumer.
  • the second surface 112 is exposed to ambient, conditions during the finishing of the raw shape.
  • the first surface 110 may be tacky (especially if the first layer 106 is an adhesive layer) after removal from the substrate, and it may adhere to the skin of a consumer, '
  • the second surface 112 may "dry out” during transformation to the multilayered film product 100.
  • the tacky first, surface 110 can be ideal for delivery of a benefit agent to the skin of the consumer.
  • the term "benefit agent” and variants thereof relates to an element, an ion, a compound (e.g., a synthetic compound or a compound isolated from a natural source) or other chemical moiety in solid (e.g. particulate), liquid, or gaseous state and compound that has a cosmetic or therapeutic effect on the skin.
  • a compound e.g., a synthetic compound or a compound isolated from a natural source
  • other chemical moiety in solid (e.g. particulate), liquid, or gaseous state and compound that has a cosmetic or therapeutic effect on the skin.
  • compositions of the present invention may further include one or more benefit agents or pharmaceutically-acceptable salts and/or esters thereof, the benefit agents generally capable of interacting with the skin to provide a benefit thereto.
  • benefit agent includes any active ingredient that is to be delivered into and/or onto the skin at a desired location, such as a cosmetic or p iar m aceutical .
  • the benefit agents useful herein may be categorized by their therapeutic benefit or their postulat ed mode of action. However, it is to be u nderstood that the benefit agents useful herein may, in some circumstances, provide more than one therapeutic benefit or operate via greater than one mode of action. Therefore, the particular classifications provided herein are made for the sake of convenience and are not intended to limit the benefit agents to the particular application(s) listed.
  • suitable benefit agents include those that provide benefits to the skin, such as, but not limited to, depigmentation agents; reflect ants; film forming polymers; amino acids and their derivatives; antimicrobial agents; allergy inhibitors; anti-acne agents; anti- aging agents; anti-wrinkling agents, antiseptics; analgesics; shine-control agents; antipruritics; local anesthetics; anti-hair loss agents; hair growth promoting agents; hair growth inhibitor agents, antihistamines; anti -infectives; anti-inflammatory agents; antich olin ergics ; vasoconstrictors;
  • vasodilators vascular endothelial growth factor receptors
  • wound healing promoters peptides, polypeptides and proteins
  • deodorants and antiperspirants medicament agents; skin firming agents, vitamins; skin lightening agents; skin darkening agents; antifungals; depilating agents;
  • the benefit agent may also provide passive benefits to the skin.
  • the benefit agent may be formulated into a composition that include s ch ingredients as humectants or emollients, softeners or conditioners of the skin, make- up preparations, a nd mixtures thereof.
  • Suitable anti-edema agents nonexclusively include bisabolol natural, synthetic bisabolol, corticosteroids, beta-glucans, and mixtures thereof.
  • suitable vasoconstrictors nonexciusively include horse chestnut extract, prickly ash, peroxides, tetrahydrozaiine, and mixtures thereof.
  • amm atory agents nonexciusively include benoxaprofen, centelia asiatica, bisabolol, feverfew (whole), feverfew (parthenolide free), green tea extract, green tea concentrate, hydrogen peroxide, salicyl ates, oat oil, chamomile, and mixtures thereof.
  • neo-coilagen enhancers nonexciusively include vitamin A and its derivatives (e.g. beta-carotene and retinoids such as retinoic acid, retinal, retinyl esters such as and retinyl palmita e, retinyl acetate and retinyl propionate); vitamin C and its derivati ves such as ascorbic acid, ascorbyl phosphates, ascorbyl palmitate and ascorbyl glucoside; copper peptides; simple sugars such as lactose, mellibiose and fructose; and mixtures thereof.
  • vitamin A and its derivatives e.g. beta-carotene and retinoids such as retinoic acid, retinal, retinyl esters such as and retinyl palmita e, retinyl acetate and retinyl propionate
  • vitamin C and its derivati ves such as ascorbic
  • enzymes examples include papain, bromelain, pepsin, and trypsin.
  • Suitable skin firming agent nonexciusively include
  • alkanolamines such as dimethylaminoethanol (“DMAE").
  • Suitable antipruritics and skin pro ectants nonexclusi vel.y include oatmeal, beta-glucan, feverfew, soy products (by "soy product,” it is meant a substance derived from soybeans, as described in U nited States Patent
  • colloidal oatmeal means the powder resulting from the grinding and further processing of whole oat grain meeting United States Standards for Number 1 or Number 2 oats.
  • the colloidal oatmeal has a particle size distribution as follows: not more than 3 percent of the total particles exceed 150 micrometers in size and not more than 20 percent of the total particles exceed 75 micrometers in size.
  • suitable colloidal oatmeals include, but are not limited to, "Tech-O” available from the Beacon Corporation (Kenilworth, J) and colloidal oatmeals available from Quaker (Chicago, IL).
  • Suitable reflectants nonexciusively include mica, alumina, calcium silicate, glycol dioleate, glycol distearate, silica, sodium magnesium fluorosilicate, and mixtures thereof.
  • suitable reflectants nonexciusively include mica, alumina, calcium silicate, glycol dioleate, glycol distearate, silica, sodium magnesium fluorosilicate, and mixtures thereof.
  • skin darkening agents nonexclusively include dihydroxy acetone, erythulose, melani n, and mixtures thereof.
  • Suitable film forming polymers include those that, upon drying, produce a substantially continuous coating or film on the ski or nails.
  • I onexclusive examples of suitable film forming polymers include aerylamidopropyi trimomum chloride/ acrylamide copolymer; cor starch/ acrylamide/ sodium acrylate copolymer; poiyquaternium- 10; poly uater niu m-47 ; polyvinylmethylether/maleic anhydride copolymer; styrene/acrylates copolymers; and mixtures thereof.
  • humectants which are capable of providing moisturization a nd conditioning properties nonexclusively include: (i) water soluble liquid polyols selected from the group comprising glycerine, propylene glycol, hexylene glycol, butylene glycol, pentylene glycol, dipropylene glycol, and mixtures thereof; (ii) polyalkylene glycol of the formula HO-(R"0)b-H wherein R" is an alkyiene group having from about 2 to about 4 carbon atoms and b is an integer of from about 1 to about 10, such as PEG 4; (iii) polyethylene glycol ether of methyl glucose of formula CH3-C6H10O5- ⁇ OCH2CH2)c-OH wherein c is an integer from about 5 to about 25; (iv) urea; (v) fructose; (vi) glucose; (vii) honey; (viii) lactic acid; (ix) maltose; (x) sodium glucuronate
  • Suitable amino acids and derivatives include amino acids derived from the hydrolysis of various proteins as well as the salts, esters, and acyl derivatives thereof.
  • Examples of such amino acid agents nonexclusively include amphoteric amino acids such as alkylamido alkylamines, i.e. steary!
  • Suitable proteins include those polymers that have a long chain, i.e. at least about 10 carbon atoms, and a high molecular weight, i.e. at least about 1000, and are formed by self-condensation of amino acids.
  • Nonexclusive examples of such proteins include collagen, deoxyribonuclease, iodized cor n protein; milk protein; protease; serum protein; silk; sweet almond protein; wheat germ protein; wheat protein; alpha and beta helix of keratin proteins; hair proteins, such as intermediate fila ment proteins, high-sulfur proteins, ultra high-sulfur proteins, intermediate filament-associated proteins, high-tyrosine proteins, high-glycine tyrosine proteins, tricohyaiin, and mixtures thereof.
  • vitamins nonexclusively include various forms of vitamin B complex, including thiamine, nicotinic acid, biotin, pantothenic acid, choline, riboflavin, vitamin B3, vitamin B6, vitamin B1.2, pyridox ine, inositol, carnitine; vitamins A,C,D,E, and their derivatives such as vitamin A palmitate and pro-vitamins, e.g. (i.e., panthenol (pro vitamin B5) and panthenol triacetate) and mixtures thereof.
  • vitamin B complex including thiamine, nicotinic acid, biotin, pantothenic acid, choline, riboflavin, vitamin B3, vitamin B6, vitamin B1.2, pyridox ine, inositol, carnitine; vitamins A,C,D,E, and their derivatives such as vitamin A palmitate and pro-vitamins, e.g. (i.e., panthenol (pro vitamin B5) and panthen
  • E x amples of suitable antimicrobial agen ts nonexclusively include bacitracin, erythromycin, neomycin, tetracycline, chlortetracycline, benzethonium chloride, phenol, benzyl peroxide, metal salts or ions such as silver and its salts a nd mixtures thereof.
  • Suitable skin emollients and skin moisturizers nonexclusively include mineral oil, lanolin, vegetable oils, isostearyl isostearate, glyceryl laurate, methyl gluceth-10, methyl gluceth-20 chitosan, and mixtures thereof.
  • a n example of a suitable hair softener nonexclusively includes silicone compounds, such as those that are either non- olatile or volatile and those that are water soluble or water insoluble.
  • suitable silicones include organo- substituted polysiloxanes, which are either linear or cyclic polymers of monomeric silicone/oxygen monomers and which non exclusi ely include cetyl dimethicone; cetyl triethyl m monium dimethicone copolyoi phthalate; cyclomethicone;
  • dimethicone copolyoi dimethicone copolyoi
  • dimethicone copolyoi lactate hydrolyzed soy
  • protem dirnethicone copolyoi acetate silicone quaternium 13; stearalkonium dimethicone copolyoi phthalate; stearamidopropyl dimethicone; and mixtures thereof.
  • sunscreens nonexclusively include benzophenones, bornelone, butyl paba, cinnamidopropyl trimethyl ammonium chloride, disodium distyrylbiphenyl disulfonate, PABA and its derivatives (such as octyl dimethyl PAB A, bu tyl niethoxydibenzoylmethane, isoamyi metis oxycinnamate, methyl benzilidene camphor, octyl triazole, octyl rnethoxycinna mate, oxybenzone, octocrylene, octyl salicylate, homosalate, phenylbenzimidazole sulfonic acid, ethyl hydroxypropyl amin Tavernzo ate, men thy 1 anthr anil ate, aminobenzoic acid, cinoxate, diethanolamine methoxycinnamate, gly
  • Examples of skin lightening agents nonexclusively include hydroquinone, catechol and its derivatives, ascorbic acid and its derivatives, and mixtures thereof.
  • suitable insecticides including insect repellents, anti-scabies and anti-lice trea ments
  • n on exclusively include perme hrin, pyrethrin, piperonyl butoxide, imidacioprid, N,J -diethyl toluamide, which refers to the material containing predo minantly the meta isomer, i.e., N,J -diethyl-m-toluamide, which is also known as DEET, natural or synthetic pyrethroids, whereby the natural pyrethroids are contained in pyrethrum, the extract of the ground flowers of Chrysanthemum cinerariaefolium or C coccineum; and mixtures thereof.
  • Examples of an anti-fungal for foot preparations nonexclusively include tolnaftate and myconozole.
  • depilating agents nonexclusivel examples include calcium thioglycolate, magnesium thioglycolate, potassium thioglycolate, strontium thioglycolate, and mixtures thereof.
  • Suitable analgesics such as external analgesics and local anesthetics nonexclusively include benzocaine, dibueaine, benzyl alcohol, camphor, capsaicin, capsicum, capsicum oleoresin, juniper tar, menthol, methyl nicotinate, methyl salicylate, phenol, resorcinol, turpentine oil, and mixtures thereo .
  • suitable antiperspirants and deodorants nonexclusively include aluminium chlorohydrates, aluminium zirconium chlorohydrates, and mixtures thereof.
  • Suitable count erirritants nonexclusively include camphor, menthol, methyl salicylate, pepperm int a nd clove oils, ichtam rno!, and mixtures thereof.
  • An example of a suitable in flammation i nh ibitor nonexclusively includes hydrocortisone, Fragaria Vesca, Matricaria Chamomilla, and Salvia Officinalis.
  • Suitable anaesthetic ingredients nonexclusively include the henzocaine, pra moxine hydrochloride, lidocaine, betacaine and mixtures thereof; antiseptics such as benzethonium chloride: astringents such as zinc oxide, bismuth subgallate, balsa m Peru, and mixtures thereof; skin protectants such as zinc oxide, silicone oils, petrolatum, cod liver oil, vegetable oil, and mixtures thereof.
  • Suitable benefits agents effective in the treatment of dandruff, seborrheic dermatitis, and psoriasis, as well as the symptoms associated therewith non exclusi ely include zinc pyrithione, anthraiin, shale oil and derivatives thereof such as sulfonated shale oil, selenium sulfide, sulfur; salicylic acid; coal tar; povidone-iodine, imidazoles such as ketoconazoie, dichlorophenyl imidazolodioxalan C'elubioi"), clotrimazole, itraconazole, miconazole, climbazole, tioconazole, sulconazole, butoconazole, fluconazole, miconazole nitrate and any possible stereo isomers and derivatives thereof; piroctone oia mine (Octopirox); ciclopirox oiamine; anti-psoriasis agents
  • benefit agents suitable for treating h air loss include, but are not limited to potassium channel openers or peripheral vasodilators such as minoxidil, diazoxide, and compounds such as j *-cyano-J -(tert-pentyr)-j '-3-pyridinyl- guanidine ("P-1075"); saw palmetto extract, vitamins, such as vitamin E and vitamin C.
  • vitamin E acetate and vitamin C palmitate such as vitamin E acetate and vitamin C palmitate; hormones, such as erythropoietin, prostaglandins, such as prostaglandin El and prostaglandin F2-aipha; fatty acids, such as oleic acid; diruretics such as spironolactone; heat shock proteins ('HSP"), such as HSP 27 and HSP 72; calcium channel blockers, such as verapamil HCL, nifedipine, and diltiazernamiloride;
  • hormones such as erythropoietin, prostaglandins, such as prostaglandin El and prostaglandin F2-aipha
  • fatty acids such as oleic acid
  • diruretics such as spironolactone
  • heat shock proteins 'HSP"
  • HSP 27 and HSP 72 heat shock proteins
  • calcium channel blockers such as verapamil HCL, nifedipine, and dilti
  • immunosuppressant d rugs such as cyclosporin and Fk-506; 5 alpha-reductase inhibitors such as finasteride; growth factors such as, EGF, IG F and FGF;
  • transforming grow th factor beta tumor necrosis factor
  • non-steroidal antiinflammatory agents such as benox aprof en
  • retinoids such as retinal and tretinoin
  • cytokines such as IL-6, IL-1 alpha, and !L-1 beta
  • ceil adhesion molecules such as I CAM
  • glucorcorticoids such as betametasone
  • botanical extracts such as aloe, clove, ginseng, rehmannia, swertia, sweet orange, zanthoxylum, Serenoa repens (saw palmetto), Hypoxis rooperi, stinging nettle, pumpkin seeds, and rye pollen
  • other botanical extracts including sandlewood, red beet root, chrysanthemum, rosemary, burdock root and other hair growth promoter activators
  • homeopathic agents such as Kaiium Phosphoricum D2, Azadirachta indica D2, and Joborandi DI
  • ketoconazole and elubiol antibiotics such as streptomycin; proteins inhibitors such as cycloheximide; acetazolamide; benoxaprofen; cortisone; diltiazem;
  • pinacidil pinacidil
  • psoralens verapamil
  • zidovudine alpha-glucosylated rutin having at least one of the following rutins: quercetin, isoquercitrin, hespeddin, naringin, and methylhesperidin, and f!avonoids and transglycosidated derivatives thereof; and mixtures thereof,
  • benefit agents suitable for use in inhibiting hair growth include: serine proteases such as trypsin; vitamins such as alph a - t ocophenol ( vitamin E) and derivatives thereof such as tocophenol acetate and tocophenol palmitate;
  • antineoplastic agents such as doxorubicin, cyclophosphamide, chlormethine, methotrexate, fluorouracil, vincristine, daunorubicin, bleomycin and
  • anticoagulants such as heparin, heparinoids, coumaerins, detran and indandiones
  • antithyroid drugs such as iodine, thio uracils and
  • carbimazole lithium and lithium carbonate
  • interferons such as interferon alpha, interferon aipha-2a and interferon alpba-2b
  • retinoids such as retinol (vitamin A), isotretinoin: glucocorticoids such as betamethasone, and dexamethosone
  • glucocorticoids such as betamethasone, and dexamethosone
  • antihyperlipidaemic drugs such as triparanol a nd clofibrate; thallium; mercury; albendazole; aliopurinol; amiodarone; amphe ( amines; androgens; bromocriptine; butyrophenones; carbamazepine; cholestyramine; cimetidine; clofibrate; danazol; desipramine; dixyrazi ne; ethambutol; et h iona ide; fluoxetine; genJ a mac, gold salts; hydantoins; ibuprofen; impramine; immunoglobulins; indandiones; indomethacin; levadopa; maprotiline; met ' hysergide; metoprolol; metyrapone;
  • nadolol nicotinic acid; potassium thiocyanate; propranolol; pyridostimine;
  • salicylates sulfasalazine; terfenadine; thiamphenicol; thio uracils; trimethadione; tropara nol; valproic acid; and mixtures thereof.
  • Suitable anti-aging agents include, but are not limited to inorganic sunscreens such as tit a nium diox ide and zi nc oxide; organic sunscreens such as octyl-rnethoxy cinnarnat.es and derivatives thereof; retinoids; copper containing peptides; vitamins such as vitamin E, vitamin A, vitamin C, vitamin B, and derivatives thereof such as vitamin E acetate, vitamin € palmitate, and the like; antioxidants including beta carotene, alpha hydroxy acids such as giycolic acid, citric acid, lactic acid, malic acid, mandelic acid, ascorbic acid, alpha- hydroxybutyrie acid, alpha-hydroxyisobutyric acid, alpha-hydroxyisocaproic acid, aJ rrolaeJ ic acid, aipha-bydroxy isovalerie acid, ethyl pyruvate, gaiaeturosiie acid, glucoheptonic
  • Suitable anti-acne agents include, but are not limited to topical retinoids (tretinoin, isotretinoin, motretinide, adapalene, tazarotene, azelaic acid, retinol); salicylic acid; benzoyl peroxide; resorcinol; antibiotics such as tetracycline and isomers thereof, erythromycin, and the anti-inflammatory agents such as ibuprofen, naproxen, hetprofen; botanical extracts such as alnus, arnica, artemisia capillaris, asiasarum root, birrh, calendula, chamomile, cnidium, conifrey, fennel, galla rhois, hawthorn, houttuyaia, hypericum, jujube, kiwi, licorice, magnolia, olive, peppermint, phiiodendron, salvia,
  • depigmentation agents include, but are not limited to soy products, retinoids such as retinol; Kojic acid and its derivatives such as, for example, kojic dipalmita te; hydroquinone and it derivatives such as arbutin;
  • transexamic acid vitamins such as niacin, vitamin € and its derivatives: azelaic acid; placertia; licorice; extracts such as chamomile and green tea, and mixtures thereof, with retinoids, Kojic acid, soy products, and hydroquinone being particularly suitable examples.
  • Suitable an ti-hemorrh oida 1 products include, but are not limited to anesthetics such as benzocaine, pramoxine hydrochloride, and mixtures thereof antiseptics such as benzethonium chloride; astringents such as zinc oxide, bismuth subgallate, balsam Peru, and mixtures thereof; skin protectants such as cod liver oil, vegetable oil, and mixtu res thereof.
  • anesthetics such as benzocaine, pramoxine hydrochloride, and mixtures thereof antiseptics such as benzethonium chloride
  • astringents such as zinc oxide, bismuth subgallate, balsam Peru, and mixtures thereof
  • skin protectants such as cod liver oil, vegetable oil, and mixtu res thereof.
  • vasodilators include, but are not limited to minoxidil, diazoxide, and compounds such as * -cy ano - N - ( tert-penty 1) -I ' - 3 -pyridinyl- gu a Eii dine ( " P - 1075").
  • Suitable shine-control agents include, but are not limited to hydrated silica, kaolin, and bentonite.
  • suitable anti-histamines include, but are not limited to diphenhydramine HQ.
  • suitable antiinfectives include, but are not limited to benzaikonium chloride, hexamidine, and hydrogen peroxide.
  • suitable wound healing promoters include, but are not limited to chitosan a nd its deri atives.
  • suitable poison ivy and poison oak products include, but are not limited to bentonite, hydrocortisone, menthol, and lidocaine.
  • burn products include, but are not limited to benzocaine and lidocaine.
  • Suitable anti-diaper rash products include but are not limited to zinc oxide and petrolatum.
  • suitable prickly heat products include, but are not limited to zinc oxide.
  • suitable sensates include, but are not limited to menthol, fragrances, and capsaicin.
  • Benefit agents that may he particularly suitable for use with the shaped film product 100 include, DMAE, soy products, colloidal oatmeal, sulfonated shale oil, olive leaf, elubiol, 6-(l-piperidii]yl)-2,4-pyrimidmediami[ie-3-oxide, finasteride, ketoconazole, salicylic acid, zinc pyrithione, coal tar, benzoyl peroxide, selenium sulfide, hydrocortisone, sulfur, menthol, pramoxine hydrochloride, tricetylmoniurn chloride, polyquaternium 10, panthenol, panthenol triacetate, vitamin A and derivatives thereof, vitamin B and derivatives thereof, vitamin C and derivatives thereof, vitamin D and derivatives thereof, vitamin E and derivatives thereof, vitamin K and derivatives thereof, keratin, lysine, arginine, liydrolyzed wheat proteins, copper cont aining
  • Benefit agents that may be of particularly suitable for use the shaped film productlOO include neo-collagen promoters (e.g. retinoids such as retinal and copper-containing peptides), skin firm ing agents (e.g. DMAE ⁇ , and depigmenting agents (e.g. soy).
  • neo-collagen promoters e.g. retinoids such as retinal and copper-containing peptides
  • skin firm ing agents e.g. DMAE ⁇
  • depigmenting agents e.g. soy
  • the amount of the benefit agent that may be used may var y depending upon, for example, the ability of the benefit agent to penetrate through the skin or nail, the specific benefit agent chosen, the particular benefit desired, the sensitivity of the user to the benefit agent, the health condition, age, a nd skin and/or nail condition of the user, and the like.
  • the benefit agent is used in a "'safe and effective amount," which is an amount, that is high enough to deliver a desired skin or nail benefit or to modify a certain condition to be treated, but is low enough to avoid serious side effects, at a reasonable risk to benefit ratio within the scope of sound med ical judgment.
  • the benefit agent may be formulated, mixed, or compounded with other ingredients into a composition (e.g. liquid, emulsion, cream, and the like) wherein the other ingredients do not detract from the functionality of the benefit agent.
  • a composition e.g. liquid, emulsion, cream, and the like
  • a deli very agent that enhances the absorption of the one or more benefit agents into the skin may be formulated with the benefit agent to fulfill this function.
  • Suitable delivery agents include, for example, sulfoxides, alcohols such as ethanol; fatty acids such as, for example, lin oleic acid or oleic acid, fatty esters such as, for example, may be produced from reacting a C3-C10 carboxylic acid with a C10-C20 fatty alcohol; a polyol, an alkane, an a mine, an amide, a turpene, a surfactant, a cyclodextrin or combinations thereof among other agents known to the art to be suitable for enhancing the penetration of various benefit agents through the stratum corneum into deeper layers of the skin.
  • the concentration of the benefit agent w ithin the composition is variable. Unless otherwise expressed herein, typically the benefit agent is present in the composition in an amount, based upon the total weight of the composition/system , from about 0.01 percent to about 20 percent, such as from about 0.01 percent to about 5 percent (e.g., from about 0.01 percent to about 1 percent).
  • composition that includes the benefit agent may also serve as a coupling composition as described previously and may include ingredients that enable the composition to possess one of these functions.
  • fragrances, flavors, sweeteners, coloring agents, pigments, dyes and the like may be added to the film-forming composition of the present invention.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Mechanical Engineering (AREA)
  • Cosmetics (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Coating Apparatus (AREA)
  • Casting Or Compression Moulding Of Plastics Or The Like (AREA)
  • Medicinal Preparation (AREA)
  • Moulds For Moulding Plastics Or The Like (AREA)

Abstract

L'invention porte sur un procédé comprenant la mise en place d'un masque sur un substrat ; la distribution de compositions filmogènes liquides dans le masque vers le substrat ; le retrait du masque pour laisser une forme brute multicouche sur le substrat ; et le durcissement de la forme brute multicouche pour former le produit sous forme de film mis en forme multicouche disposé sur le substrat. Le masque comprend une surface de distribution, une surface opposée et au moins une ouverture ayant un dessin correspondant au produit sous forme de film mis en forme souhaité. Les compositions filmogènes sont distribuées par une buse à plusieurs flux. Le mouvement du masque et la distribution des première et seconde compositions filmogènes liquides vers l'ouverture du masque sont réglés pour assurer un débit volumique des première et seconde compositions filmogènes liquides vers l'ouverture du masque correspondant au volume d'un vide. La buse est en contact avec la surface de distribution du masque.
PCT/US2014/072109 2013-12-31 2014-12-23 Procédé en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche WO2015103034A1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
AU2014374017A AU2014374017B2 (en) 2013-12-31 2014-12-23 Single-pass process for forming a multilayered shaped film product
CN201480071872.5A CN105873737A (zh) 2013-12-31 2014-12-23 形成多层成型膜产品的单程方法
RU2016131259A RU2676288C2 (ru) 2013-12-31 2014-12-23 Способ формирования многослойного формованного пленочного продукта в один проход
ES14835741T ES2703210T3 (es) 2013-12-31 2014-12-23 Proceso en un solo paso para la formación de un producto en la forma de película de capas múltiples, producto y aparato
JP2016543679A JP6517216B2 (ja) 2013-12-31 2014-12-23 多層賦形フィルム製品を形成するための単一パス方法
CA2935219A CA2935219C (fr) 2013-12-31 2014-12-23 Procede en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche
MX2016008679A MX2016008679A (es) 2013-12-31 2014-12-23 Proceso de una sola pasada para formar un producto de película conformada en capas múltiples.
EP14835741.1A EP3089854B1 (fr) 2013-12-31 2014-12-23 Procédé en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche, produit et dispositif
BR112016015347A BR112016015347B8 (pt) 2013-12-31 2014-12-23 Processo para a formação de um produto de filme dotado de um formato em camadas múltiplas, produto de filme dotado de um formato em camadas múltiplas e aparelho para formar um produto de filme dotado de um formato em camadas múltiplas
KR1020167020648A KR102226596B1 (ko) 2013-12-31 2014-12-23 다층의 형상화된 필름 제품을 형성하기 위한 단일 통과 방법

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361922318P 2013-12-31 2013-12-31
US61/922,318 2013-12-31

Publications (1)

Publication Number Publication Date
WO2015103034A1 true WO2015103034A1 (fr) 2015-07-09

Family

ID=52469287

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/072109 WO2015103034A1 (fr) 2013-12-31 2014-12-23 Procédé en une seule passe pour la formation d'un produit sous forme de film mis en forme multicouche

Country Status (12)

Country Link
US (3) US9839939B2 (fr)
EP (1) EP3089854B1 (fr)
JP (1) JP6517216B2 (fr)
KR (1) KR102226596B1 (fr)
CN (1) CN105873737A (fr)
AU (1) AU2014374017B2 (fr)
BR (1) BR112016015347B8 (fr)
CA (1) CA2935219C (fr)
ES (1) ES2703210T3 (fr)
MX (1) MX2016008679A (fr)
RU (1) RU2676288C2 (fr)
WO (1) WO2015103034A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108027689A (zh) * 2015-09-30 2018-05-11 住友金属矿山株式会社 有机皮膜的制造方法、导电性基板的制造方法、有机皮膜制造装置

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3091968A1 (fr) 2013-12-31 2016-11-16 Johnson & Johnson Consumer Inc. Procédé de formation d'un film façonné multicouche
ES2909467T3 (es) 2013-12-31 2022-05-06 Johnson & Johnson Consumer Inc Proceso para formar un producto de película con forma
EP3328930B1 (fr) * 2015-07-27 2019-05-29 Dow Global Technologies LLC Procédé de fabrication additive de matériau biocompatible et articles réalisés à l'aide du procédé
US10821297B2 (en) 2016-09-30 2020-11-03 Johnson & Johnson Consumer Inc. Kit and method for topical delivery of benefits
US10596134B2 (en) 2017-02-08 2020-03-24 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using light and polycarboxylic acids
CN107262326A (zh) * 2017-07-17 2017-10-20 江西丰临医疗科技股份有限公司 一种导管涂层浸涂固化装置
CN108081527B (zh) * 2017-09-22 2021-07-20 纳智源科技（唐山）有限责任公司 用于制备高分子聚合物膜的模具、高分子聚合物膜的制备方法以及摩擦发电机的制备方法
US11241374B2 (en) 2018-06-28 2022-02-08 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using light and glucosamine hydrochloride
US20200405603A1 (en) 2019-06-25 2020-12-31 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using infrared light and resorcinols
US10537534B1 (en) 2019-06-25 2020-01-21 Johnson & Johnson Consumer Inc. Compositions and methods for treating skin conditions using visible light and resorcinols
CN111514064A (zh) * 2020-05-07 2020-08-11 广州市美夫兰化妆品有限公司 一种西林瓶冻干面膜及其制备方法
CN111595379B (zh) * 2020-05-22 2022-05-10 合肥工业大学 一种矩形多流道检测装置及方法
CN112871578B (zh) * 2021-01-19 2022-07-22 北京亚宝生物药业有限公司 一种贴剂制备装置及制备方法
US11548192B1 (en) 2022-04-19 2023-01-10 King Abdulaziz University System, apparatus, and methods for manufacturing biodegradable biopolymeric materials

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2523670A (en) * 1946-06-05 1950-09-26 Schueler Engineering Co Process of producing plastic patterns of irregular outlines
FR2710869A1 (fr) * 1993-10-08 1995-04-14 M3B Matériau multicouches et fabrication de celui-ci par coulée de la matière de revêtement sur la couche de base.
WO2009084234A1 (fr) * 2007-12-27 2009-07-09 Kao Corporation Préparation de feuille devant être appliquée sur le corps humain
EP2472331A1 (fr) * 2010-04-19 2012-07-04 Beijing BOE Optoelectronics Technology Co., Ltd. Dispositif et procédé de gommage

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2511511A (en) * 1947-04-11 1950-06-13 Lawrence Atkins S Rotary screen printing machine
NL7302664A (fr) * 1973-02-26 1974-08-28
FR2249541A5 (fr) 1973-10-24 1975-05-23 Duchenaud Alain
US4068994A (en) 1976-11-11 1978-01-17 International Business Machines Corporation Apparatus for the printing of ceramic green sheets
JPS57170732A (en) 1981-04-15 1982-10-21 Matsushita Electric Works Ltd Manufacture of building board
US4466431A (en) 1981-05-09 1984-08-21 Smith And Nephew Associated Companies Limited Dressings, manufacture and use
DE3423328A1 (de) 1984-06-23 1986-01-02 Beiersdorf Ag, 2000 Hamburg Selbstklebendes pflaster
JPS63171565A (ja) 1987-01-07 1988-07-15 積水化学工業株式会社 口腔粘膜貼付用構成体およびその製造方法
US4990339A (en) 1987-11-16 1991-02-05 H. B. Fuller Company Dermal treatment film
US5264269A (en) 1989-09-21 1993-11-23 Kao Corporation Water-disintegratable cleaning article in laminated sheet form
DE3933460A1 (de) 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
US5251566A (en) 1990-08-31 1993-10-12 Ricoh Company, Ltd. Stencil printer with a cam baissed press roller
EP0565151A3 (en) 1992-04-09 1993-11-24 Ibm Manufacture of multi-layer ceramic interconnect structures
EP0568219B1 (fr) 1992-04-20 1996-09-18 Riso Kagaku Corporation Procédé pour imprimer au pochoir et dispositif d'impression avec production de la plaque
JP3217193B2 (ja) * 1993-06-30 2001-10-09 サン−ゴバン ビトラージュ 複層フィルムの製造方法
CA2169729C (fr) 1993-08-19 2001-04-03 James E. Biegajski Adhesif a simple pression, soluble dans l'eau
JPH07251560A (ja) 1994-03-14 1995-10-03 Riso Kagaku Corp 輪転式孔版印刷装置
US5553536A (en) 1994-10-03 1996-09-10 Van Os Enterprises Screen printing apparatus with vacuum conveyor belt
JP3029540B2 (ja) 1994-11-01 2000-04-04 メルヘンワールド株式会社 熱可塑性樹脂製品の流し込みマスキング成形方法
JP3474981B2 (ja) 1995-10-11 2003-12-08 花王株式会社 浴用剤
JP2791317B2 (ja) 1995-12-26 1998-08-27 株式会社三和化学研究所 多層フィルム製剤
US5622108A (en) 1996-01-30 1997-04-22 Universal Screenprinting Systems, Inc. Screen printing machine
CA2250025C (fr) 1996-03-25 2006-10-31 Lts Lohmann Therapie-Systeme Gmbh Systeme therapeutique transdermique a faible epaisseur de la zone d'application et a grande souplesse, et son procede de fabrication
US5814260A (en) 1996-04-29 1998-09-29 Arai; Takeshi Method of casting-masking-molding thermoplastic resin product
US5746127A (en) 1996-05-03 1998-05-05 Amtx, Inc. Electroformed squeegee blade for surface mount screen printing
US5800832A (en) 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
US5925414A (en) 1996-11-20 1999-07-20 International Business Corpration Nozzle and method for extruding conductive paste into high aspect ratio openings
US6132510A (en) 1996-11-20 2000-10-17 International Business Machines Corporation Nozzle apparatus for extruding conductive paste
JPH10156849A (ja) * 1996-11-27 1998-06-16 Araco Corp 積層体の製造方法
US5976694A (en) 1997-10-03 1999-11-02 Kimberly-Clark Worldwide, Inc. Water-sensitive compositions for improved processability
US6092464A (en) 1998-03-19 2000-07-25 M J Grant Company Three-dimensional raised image screen printing
US20020127254A1 (en) 1998-06-25 2002-09-12 Lavipharm Laboratories Inc. Devices for local and systemic delivery of active substance and methods of manufacturing thereof
US20030211136A1 (en) 1998-09-25 2003-11-13 Neema Kulkarni Fast dissolving orally consumable films containing a sweetener
JP2000118113A (ja) 1998-10-15 2000-04-25 Riso Kagaku Corp 孔版印刷方法及び装置
US6238741B1 (en) 1998-12-07 2001-05-29 International Business Machines Corporation Single mask screening process
NL1011993C2 (nl) 1999-05-07 2000-11-09 Stork Brabant Bv Zeefdrukinrichting met een in een sjabloon verplaatsbare reinigingseenheid.
DE19954245A1 (de) 1999-11-11 2001-07-19 Lohmann Therapie Syst Lts Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen
BR0007360A (pt) 1999-12-23 2001-08-14 Johnson & Johnson Composição de liberação controlada
KR100721088B1 (ko) 2000-04-26 2007-05-23 신에쓰 가가꾸 고교 가부시끼가이샤 필름 코팅층으로 피복된 고형제제 및 필름 코팅제
EP1149547A1 (fr) 2000-04-28 2001-10-31 Hugo Bastiaens Matelas ou coussin adaptable individuellement
US6537663B1 (en) 2000-05-04 2003-03-25 Kimberly-Clark Worldwide, Inc. Ion-sensitive hard water dispersible polymers and applications therefor
US6429261B1 (en) 2000-05-04 2002-08-06 Kimberly-Clark Worldwide, Inc. Ion-sensitive, water-dispersible polymers, a method of making same and items using same
US6548592B1 (en) 2000-05-04 2003-04-15 Kimberly-Clark Worldwide, Inc. Ion-sensitive, water-dispersible polymers, a method of making same and items using same
US6444214B1 (en) 2000-05-04 2002-09-03 Kimberly-Clark Worldwide, Inc. Ion-sensitive, water-dispersible polymers, a method of making same and items using same
US6576575B2 (en) 2000-05-15 2003-06-10 Kimberly-Clark Worldwide, Inc. Dispersible adherent article
US7229665B2 (en) * 2001-05-22 2007-06-12 Millipore Corporation Process of forming multilayered structures
FR2810238B1 (fr) 2000-06-15 2002-07-19 Oreal Composition cosmetique filmogene
JP2002042551A (ja) 2000-07-21 2002-02-08 Murata Mfg Co Ltd スクリーン印刷用ペースト、スクリーン印刷方法及び厚膜焼成体
US20020192287A1 (en) 2000-11-09 2002-12-19 Mooney Mark T. Extrudable compositions for topical or transdermal drug delivery
US20020098994A1 (en) 2001-01-22 2002-07-25 Alam Zafar One time use disposable paper soap and method of making
US6946501B2 (en) 2001-01-31 2005-09-20 The Procter & Gamble Company Rapidly dissolvable polymer films and articles made therefrom
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6595129B2 (en) 2001-07-31 2003-07-22 Tohoku Ricoh Co., Ltd. Heat-sensitive stencil, process of preparing stencil printing master and stencil printer
US6722275B2 (en) 2001-09-28 2004-04-20 Photo Stencil, Llc Reservoir stencil with relief areas and method of using
JP2003126761A (ja) * 2001-10-29 2003-05-07 Konica Corp 塗布方法
US20030175333A1 (en) 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
US20030235606A1 (en) 2002-06-21 2003-12-25 Nussen Kenneth H. Oral hygiene products and methods of making oral hygiene products
US20030235630A1 (en) 2002-06-21 2003-12-25 Nussen Kenneth H. Dental hygiene products and methods of making dental hygiene products
US6800295B2 (en) 2002-10-09 2004-10-05 The Dial Corporation Water soluble sheet composition
ITMI20022343A1 (it) 2002-11-05 2004-05-06 Biofarm Srl Pellicola a rapida dissoluzione in acqua, contenente sistanze cosmetiche, aromatiche, farmaceutiche o alimentari.
US20040180077A1 (en) 2003-03-05 2004-09-16 Riker Donald K. Rapidly dissolving edible strips for treating obesity
AU2004259006B2 (en) 2003-07-24 2010-10-07 Glaxosmithkline Llc Orally dissolving films
US7285520B2 (en) 2003-12-01 2007-10-23 Kimberly-Clark Worldwide, Inc. Water disintegratable cleansing wipes
US7378360B2 (en) 2003-12-17 2008-05-27 Kimberly-Clark Worldwide, Inc. Water dispersible, pre-saturated wiping products
US7316791B2 (en) * 2003-12-30 2008-01-08 E.I. Du Pont De Nemours And Company Polyimide based substrate comprising doped polyaniline
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
US6989327B2 (en) 2004-01-31 2006-01-24 Hewlett-Packard Development Company, L.P. Forming a contact in a thin-film device
ATE345208T1 (de) * 2004-03-19 2006-12-15 Recticel Herstellungsverfahren eines plattenaufbaus mit dichtung
DE602005015506D1 (de) 2004-04-28 2009-09-03 Shinetsu Chemical Co Filmzubereitung und Verfahren zu deren Herstelllung
AU2005265249A1 (en) 2004-06-22 2006-01-26 E-L Management Corp. Dissolvable film composition
JP4835135B2 (ja) 2005-12-06 2011-12-14 ソニー株式会社 画像表示装置、画像表示方法、および、プログラム
US20070298087A1 (en) 2006-06-27 2007-12-27 Biegajski James E Two-phase mucoadhesive composition
DE102008007245B4 (de) 2007-02-28 2010-10-14 Siemens Aktiengesellschaft Kombiniertes Strahlentherapie- und Magnetresonanzgerät
JP4897602B2 (ja) 2007-07-25 2012-03-14 東北リコー株式会社 孔版印刷装置におけるコーティング装置およびコーティングユニット
KR100992304B1 (ko) 2008-08-29 2010-11-05 삼성전기주식회사 롤투롤타입의 박막패턴 형성장치
EP2355771B1 (fr) 2008-12-08 2015-02-25 The Procter and Gamble Company Substrats solides, solubles et poreux et complexe parfum cyclodextrine situé en surface
BRPI1015153B1 (pt) 2009-04-01 2020-01-14 Itw Ireland aplicação para fornecer um desing sobre um tecido.
MX2012006247A (es) 2009-12-08 2012-06-19 Procter & Gamble Un sustrato solido soluble poroso y un recubrimiento fijo de superficie de acondicionador de surfactante cationico.
JP5678081B2 (ja) 2009-12-08 2015-02-25 ザ プロクター アンド ギャンブルカンパニー パーソナルケア物品の製造方法
US8920867B2 (en) * 2010-10-19 2014-12-30 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US8632839B2 (en) * 2010-10-19 2014-01-21 Covidien Lp Methods of forming self-supporting films for delivery of therapeutic agents
US9149959B2 (en) * 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
WO2012104834A1 (fr) 2011-02-03 2012-08-09 Pharmedica Ltd. Nouveaux films à dissolution orale pour administration d'insuline, pour traitement du diabète
JP5834458B2 (ja) 2011-04-13 2015-12-24 株式会社ニコン 光学素子の製造方法および光学素子
JP2013188872A (ja) * 2012-03-12 2013-09-26 Nishikawa Communications Co Ltd ライナーレスラベル製造装置
WO2014116770A1 (fr) 2013-01-23 2014-07-31 Arx, Llc Production de constructions de doses unitaires

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2523670A (en) * 1946-06-05 1950-09-26 Schueler Engineering Co Process of producing plastic patterns of irregular outlines
FR2710869A1 (fr) * 1993-10-08 1995-04-14 M3B Matériau multicouches et fabrication de celui-ci par coulée de la matière de revêtement sur la couche de base.
WO2009084234A1 (fr) * 2007-12-27 2009-07-09 Kao Corporation Préparation de feuille devant être appliquée sur le corps humain
EP2472331A1 (fr) * 2010-04-19 2012-07-04 Beijing BOE Optoelectronics Technology Co., Ltd. Dispositif et procédé de gommage

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108027689A (zh) * 2015-09-30 2018-05-11 住友金属矿山株式会社 有机皮膜的制造方法、导电性基板的制造方法、有机皮膜制造装置
CN108027689B (zh) * 2015-09-30 2021-03-23 住友金属矿山株式会社 有机皮膜的制造方法、导电性基板的制造方法、有机皮膜制造装置

Also Published As

Publication number Publication date
US20170354990A1 (en) 2017-12-14
CA2935219C (fr) 2022-01-11
US10016784B2 (en) 2018-07-10
AU2014374017B2 (en) 2018-09-13
US20170368568A1 (en) 2017-12-28
KR20160105459A (ko) 2016-09-06
US9839939B2 (en) 2017-12-12
KR102226596B1 (ko) 2021-03-12
EP3089854B1 (fr) 2018-11-21
JP6517216B2 (ja) 2019-05-22
MX2016008679A (es) 2017-03-08
JP2017504474A (ja) 2017-02-09
BR112016015347B1 (pt) 2021-01-05
AU2014374017A1 (en) 2016-07-07
ES2703210T3 (es) 2019-03-07
EP3089854A1 (fr) 2016-11-09
RU2016131259A (ru) 2018-02-06
CA2935219A1 (fr) 2015-07-09
CN105873737A (zh) 2016-08-17
RU2016131259A3 (fr) 2018-06-20
US20150182990A1 (en) 2015-07-02
RU2676288C2 (ru) 2018-12-27
BR112016015347B8 (pt) 2022-07-19

Similar Documents

Publication Publication Date Title
US11203037B2 (en) Apparatus for forming a shaped film product
US10016784B2 (en) Apparatus for forming a multilayered shaped film product
US11247226B2 (en) Process for forming a multilayered shaped film product
US20150182991A1 (en) Process for forming an integral film product

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14835741

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2935219

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2016543679

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: MX/A/2016/008679

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2014374017

Country of ref document: AU

Date of ref document: 20141223

Kind code of ref document: A

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112016015347

Country of ref document: BR

ENP Entry into the national phase

Ref document number: 20167020648

Country of ref document: KR

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2014835741

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2014835741

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2016131259

Country of ref document: RU

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 112016015347

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20160630